DK4065134T3 - Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt - Google Patents

Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt Download PDF

Info

Publication number
DK4065134T3
DK4065134T3 DK20812152.5T DK20812152T DK4065134T3 DK 4065134 T3 DK4065134 T3 DK 4065134T3 DK 20812152 T DK20812152 T DK 20812152T DK 4065134 T3 DK4065134 T3 DK 4065134T3
Authority
DK
Denmark
Prior art keywords
iron
patients
treatment
oral administration
heart failure
Prior art date
Application number
DK20812152.5T
Other languages
English (en)
Inventor
Kurt Boman
Mona Olofsson
Original Assignee
Double Bond Pharmaceutical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Double Bond Pharmaceutical AB filed Critical Double Bond Pharmaceutical AB
Application granted granted Critical
Publication of DK4065134T3 publication Critical patent/DK4065134T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK20812152.5T 2019-11-26 2020-11-18 Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt DK4065134T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1951352 2019-11-26
PCT/SE2020/051104 WO2021107835A1 (en) 2019-11-26 2020-11-18 Oral administration of iron succinate for use in treating iron deficiency in patients having heart failure

Publications (1)

Publication Number Publication Date
DK4065134T3 true DK4065134T3 (da) 2024-01-22

Family

ID=73554483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20812152.5T DK4065134T3 (da) 2019-11-26 2020-11-18 Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt

Country Status (7)

Country Link
US (1) US20220395530A1 (da)
EP (1) EP4065134B1 (da)
DK (1) DK4065134T3 (da)
ES (1) ES2968183T3 (da)
FI (1) FI4065134T3 (da)
PL (1) PL4065134T3 (da)
WO (1) WO2021107835A1 (da)

Also Published As

Publication number Publication date
US20220395530A1 (en) 2022-12-15
WO2021107835A1 (en) 2021-06-03
EP4065134A1 (en) 2022-10-05
ES2968183T3 (es) 2024-05-08
EP4065134B1 (en) 2023-12-20
PL4065134T3 (pl) 2024-03-04
FI4065134T3 (fi) 2024-01-11

Similar Documents

Publication Publication Date Title
JP2017514871A5 (da)
EA201500934A1 (ru) Кардио- и нефропротективная противодиабетическая терапия
DK3439660T3 (da) Anvendelse af pimobendan til reduktion af hjertestørrelse og forsinkelse af udbruddet af kliniske symptomer hos patienter med asymptomatisk hjertesvigt på grund af mitralklapsygdom
DK3740182T3 (da) Madras med sensormodul til patientpleje
DK3324994T3 (da) Nx-1207 til brug i fremgangsmåder til mindskning af behovet for kirurgi hos patient, som lider af godartet prostatisk hyperplasi
DK3749308T3 (da) Behandling af patienter med klassisk fabrys sygdom med migalastat
CY1121166T1 (el) Ενωσεις για τη θεραπεια παχυσαρκιας και μεθοδοι χρησης αυτων
MA37455A1 (fr) Utilisation d'un dérivé de pyrazole dans le traitement d'exacerbations aigues d'une maladie pulmonaire obstructive chronique
DK3833425T3 (da) Medicinsk implantat i form af en omviklet manchet-elektrodeindretning
MX2018001720A (es) Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos.
BR112015007592A2 (pt) composições de enalapril
ZA202105111B (en) Pharmaceutical composition for the treatment of pulmonary arterial hypertension
IL285921A (en) Intravenous formulation including estrogens for the treatment of acute heart failure
IL283469A (en) Inhalable preparations for use in the treatment of lung diseases
DK3476395T3 (da) Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme
DK3377176T3 (da) Fremgangsmåde til behandling af patienter, der får administreret rivaroxaban sammen med verapamil
BR112018068960A2 (pt) formulações de enalapril
DK3874995T3 (da) Fremgangsmåde til at hjælpe bevægelseshæmmede med påklædning
DK3520786T3 (da) Kombination af stoffer til anvendelse i regenerativ terapi til patienter med type 1 diabetes mellitus
SI3124048T1 (sl) Sestavek za peroralno uporabo pri zdravljenju gastroezofagealne refluksne bolezni ali neugodja
DK3937948T3 (da) Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme
DK4065134T3 (da) Oral indgivelse af jernsuccinat til anvendelse til behandling af jernmangel hos patienter med hjertesvigt
PT3215143T (pt) Combinação compreendendo espirulina e palmitoíletanolamida
MA50358A (fr) Sémaglutide en thérapie médicale
IL288678A (en) Treatment of heart failure in human subjects